Delivery Order SPE2DB20D3103-SPE2DB23FN2K7
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $6,552.68 firm fixed-price delivery order for the supply of XULANE 150-35 MCG/DAY PATCH 3S medical patches. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supplies to the U.S. military and other federal healthcare programs. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) valued at $1,866.11 for the supply of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The award was made by the Defense Logistics Agency (DLA), a defense agency, under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $22,789.80 for the supply of XULANE 150-35 MCG/DAY PATCH 3S to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of October 19, 2023 and was awarded on October 18, 2023. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,109.87 Firm Fixed Price Delivery Order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,276.78, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The parent Cencora, Inc. holds a significant $999,999,999 IDC with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,170.38 firm-fixed-price delivery order is for the supply of the XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical product. The contract has an ultimate completion date of May 19, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Firm Fixed Price Delivery Order valued at $6,876.63. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the provision of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract award is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $7,159.62 for the supply of XULANE 150-35 MCG/DAY PATCH 3S to the Defense Logistics Agency (DLA). The award has an ultimate completion date of February 29, 2024, and a Firm Fixed Price pricing type. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The $1,337.97 order is for XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The IDC held by Cencora, Inc. with the DLA is valued at up to $999,999,999.00 and runs through November 2026. This single-award IDC serves as the primary vehicle for Cencora, Inc. to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,784.02 firm-fixed-price delivery order is for the provision of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within the Department of...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN2K7Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $4,563.96 Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA). The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) the DLA has with Cencora, Inc. valued at up to $999,999,999.00, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This award demonstrates Amerisourcebergen's role as a key supplier of critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other healthcare-related items, to the Department of Defense and other federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 5/1/23 |